ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Hims & Hers Appoints Senior Vice President of Mental Health Advancing Efforts to Provide the Highest Quality of Innovative Care for Anxiety and Depression

Dr. Daniel Lieberman was previously a Clinical Professor of Psychiatry and Behavioral Sciences at George Washington University

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform on a mission to help the world feel great through the power of better health, today announces a key leadership appointment, naming psychiatry and behavioral sciences industry veteran Dr. Daniel Lieberman, M.D., as the company’s Senior Vice President of Mental Health.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230314005429/en/

(Photo: Business Wire)

(Photo: Business Wire)

In this role, Dr. Lieberman will oversee the psychiatry and mental wellness strategy at Hims & Hers, working to ensure this category continues to deliver clinical excellence, a trusted customer experience, leading technology as well as innovative products and services. Dr. Lieberman will focus on further developing and expanding the availability of personalized health and wellness treatments surrounding anxiety and depression.

“In order to break down the stigma associated with mental health, we are taking a customer-centric approach that removes barriers, accelerates access, and delivers clinical excellence at its core, which is fundamental at Hims & Hers,” said Andrew Dudum, Co-Founder and Chief Executive Officer at Hims & Hers. “As Senior Vice President of Mental Health, Dr. Lieberman will leverage his proven leadership, expertise and prominence in the field to further enhance our services, and play an integral role in our efforts to modernize mental healthcare.”

Hims & Hers provides access to a variety of mental health services, including for customers who may be experiencing symptoms of anxiety or depression, which can include psychiatry services and subscription medication, therapy sessions, and free virtual support group sessions.

“I’m extraordinarily passionate about increasing access to high-quality mental healthcare as the fact is, millions of Americans today still struggle to find treatments and resources that work for them,” said Dr. Daniel Lieberman. “What piqued my interest in working with Hims & Hers is how the company is looking to revolutionize mental health services with treatments that are accessible yet tailored to individual needs, considering both their symptoms as well as preferences. In peeling back the layers of the company’s mental health platform, I was sincerely impressed to see they employ extremely high standards of care and work tirelessly to provide a welcoming, comforting, safe and effective experience for customers. It’s a privilege to play a role in making Hims & Hers’ vision for healthcare come to life.”

Dr. Lieberman brings more than two decades of leadership and industry expertise to the role. Prior to joining Hims & Hers, he served as a Clinical Professor of Psychiatry and Behavioral Sciences at George Washington University. He is a Distinguished Fellow of the American Psychiatric Association, a recipient of the Caron Foundation Research Award, and has published over 50 scientific reports on behavioral science.

He has been a trusted advisor on psychiatric topics for the U.S. Department of Health & Human Services, the U.S. Department of Commerce, and the Office of Drug & Alcohol Policy & Compliance. Dr. Lieberman studied the Great Books at St. John's College, and received his medical degree and completed his psychiatric training at New York University.

Dr. Lieberman is a renowned author with international bestseller The Molecule of More, which has been translated into more than 20 languages, and Spellbound: Modern Science, Ancient Magic, and the Unconscious Mind, an exploration of the intersection of neuroscience and mysticism as it relates to our experience of our unconscious.

​​Today’s announcement comes on the heels of a record quarterly earnings report. In Q4 2022, the company surpassed one million subscribers and reported record revenue of $526.9 million, up 94% year-over-year. To see the full Q4 2022 results, click here.

About Hims & Hers Health, Inc.

Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health.

We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. Hims & Hers normalizes health & wellness challenges—and innovates on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so the Company provides access to personalized care designed for results.

For more information, please visit https://investors.forhims.com/.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.